LEXICON PHARMACEUTICALS, INC. (LXRX)

2.29 -1.29% (-0.03)

Over 5Y: -41.0%

2026-08-28
Style
Area Line Line with markersneeds a shorter window Steps Candlesneeds a shorter window Hollow candlesneeds a shorter window Barsneeds a shorter window

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

2 4 6
2021 2022 2023 2024 2025 2026

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Revenue: 23K Q3 '21 — Operating Cash Flow: -17.1M Q3 '21 — Free Cash Flow: -17.4M Q3 '21 — Net Income: -23.1M Q4 '21 — Revenue: 14K Q4 '21 — Operating Cash Flow: -22.8M Q4 '21 — Free Cash Flow: -22.9M Q4 '21 — Net Income: -25.6M Q1 '22 — Revenue: 37K Q1 '22 — Operating Cash Flow: -23.4M Q1 '22 — Free Cash Flow: -23.5M Q1 '22 — Net Income: -23.5M Q2 '22 — Revenue: 35K Q2 '22 — Operating Cash Flow: -24.4M Q2 '22 — Free Cash Flow: -24.4M Q2 '22 — Net Income: -24.6M Q3 '22 — Revenue: 39K Q3 '22 — Operating Cash Flow: -19.4M Q3 '22 — Free Cash Flow: -19.4M Q3 '22 — Net Income: -23.4M Q4 '22 — Revenue: 28K Q4 '22 — Operating Cash Flow: -21.6M Q4 '22 — Free Cash Flow: -22.8M Q4 '22 — Net Income: -30.5M Q1 '23 — Revenue: 24K Q1 '23 — Operating Cash Flow: -31.6M Q1 '23 — Free Cash Flow: -31.9M Q1 '23 — Net Income: -31.9M Q2 '23 — Revenue: 317K Q2 '23 — Operating Cash Flow: -38.1M Q2 '23 — Free Cash Flow: -38.3M Q2 '23 — Net Income: -44.9M Q3 '23 — Revenue: 162K Q3 '23 — Operating Cash Flow: -41.6M Q3 '23 — Free Cash Flow: -41.7M Q3 '23 — Net Income: -50.5M Q4 '23 — Revenue: 702K Q4 '23 — Operating Cash Flow: -50.5M Q4 '23 — Free Cash Flow: -50.5M Q4 '23 — Net Income: -49.8M Q1 '24 — Revenue: 1.1M Q1 '24 — Operating Cash Flow: -55.1M Q1 '24 — Free Cash Flow: -55.1M Q1 '24 — Net Income: -48.4M Q2 '24 — Revenue: 1.6M Q2 '24 — Operating Cash Flow: -48.5M Q2 '24 — Free Cash Flow: -48.8M Q2 '24 — Net Income: -53.4M Q3 '24 — Revenue: 1.8M Q3 '24 — Operating Cash Flow: -53.6M Q3 '24 — Free Cash Flow: -53.9M Q3 '24 — Net Income: -64.8M Q4 '24 — Revenue: 26.6M Q4 '24 — Operating Cash Flow: -21.5M Q4 '24 — Free Cash Flow: -22M Q4 '24 — Net Income: -33.8M Q1 '25 — Revenue: 1.3M Q1 '25 — Operating Cash Flow: -43.8M Q1 '25 — Net Income: -25.3M Q2 '25 — Revenue: 28.9M Q2 '25 — Operating Cash Flow: 17M Q2 '25 — Net Income: 3.3M Q3 '25 — Revenue: 14.2M Q3 '25 — Operating Cash Flow: -23.8M Q3 '25 — Free Cash Flow: -23.8M Q3 '25 — Net Income: -12.8M Q4 '25 — Revenue: 5.5M Q4 '25 — Operating Cash Flow: -17.2M Q4 '25 — Free Cash Flow: -17.2M Q4 '25 — Net Income: -15.5M Q1 '26 — Revenue: 21.1M Q1 '26 — Operating Cash Flow: -14.7M Q1 '26 — Net Income: -1M Q2 '26 — Revenue: 692K Q2 '26 — Operating Cash Flow: -9.2M Q2 '26 — Net Income: -31.8M -60M -40M -20M 0 20M 40M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.6
SBC / sales 30.6%
OE margin -187.3%
Oper. margin -131.4%
ROIC -121.8%
Gross margin 99.1%
Accruals 1.5%
EBITDA margin -130.3%
FCF margin -156.7%
OCF margin -156.7%
Profit margin -147.4%
ROA -24.4%
ROCE -23.2%
ROE -35.0%
Capex / sales —
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

2.4
RPO / sales 0.1×
RPO growth —
Segment HHI —

4 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.5
Current ratio 18.9×
ND/EBITDA —
Cash / Debt 3.7×
Debt payback 0.0 yr
Quick ratio 13.3×
Debt / Eq 0.29×
Cash runway 2.1 yr
F-score 4.0 pts
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

7.3
Sales CAGR 4Y +259.6%
Sales/sh Y/Y -37.4%
Sales Q/Q -97.6%
Shares change +13.5%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.